Seminars in Roentgenology
Volume 42, Issue 4 , Pages 228-235 , October 2007

Breast Magnetic Resonance Imaging: Principles and Techniques

  • Werner A. Kaiser, MD, MS

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Werner A. Kaiser, MD, MS, Professor and Chairman, Institute for Diagnostic and Interventional Radiology, Friedrich-Schiller-University Jena, D-07740 Jena, Germany.

References 

  1. Damadian R. Tumour detection by nuclear magnetic resonance. Science. 1971;171:1151–1153
  2. Lauterbur PC. Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature. 1973;242:190–191
  3. Mansfield P, Morris PG, Ordidge R, et al. Carcinoma of the breast imaged by nuclear magnetic resonance (NMR). Br J Radiol. 1979;52:242–243
  4. Ross RJ, Thompson JS, Kim K, et al. Nuclear magnetic resonance imaging and evaluation of human breast tissue: preliminary clinical trials. Radiology. 1982;143:195–205
  5. El Yousef SJ, Alfidi RJ, Duchesneau RH. Initial experience with nuclear magnetic resonance (NMR) imaging of the human breast. J Comput Assist Tomogr. 1983;7:215–218
  6. El Yousef SJ, Duchesneau RH, Alfidi RJ, et al. Magnetic resonance imaging of the breast. Radiology. 1984;150:761–766
  7. Kaiser W. MRI of the female breast (First clinical results). Arch Int Physiol Biochim. 1985;93:67–76
  8. Fritschy P, Müller E, Sauter R, et al. MR-imaging with special coils for visualisation of superficial organs and structures (RSNA 1984). Radiology. 1984;153(P):243–244
  9. Stelling CB, Wang PC, Lieber A, et al. Prototype coil for magnetic resonance imaging of the female breast: work in progress. Radiology. 1985;154:457–462
  10. Kaiser W, Zeitler E. Die Kernspintomographie der Mamma—Diagnose (Differentialdiagnose, Probleme und Lösungsmöglichkeiten Teil I: Untersuchungsverfahren). Fortschr Röntgenstr. 1986;144:459–4655
  11. Kaiser W, Zeitler E. Die Kernspintomographie der Mamma—Diagnose (Differentialdiagnose, Probleme und Lösungsmöglichkeiten Teil II: Diagnostik). Fortschr Röntgenstr. 1986;144:572–5795
  12. Heywang SH, Fenzl G, Edmaier M. Kernspintomographie in der Mammadiagnostik. RÖFO. 1985;143:207–212
  13. Weinmann HJ, Laniado M, Mützel W. Pharmacokinetics if gadolinium-DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NRM. 1984;16:167–172
  14. Eskin BA, Parker JA, Bassett JG. Human breast uptake of radioactive iodine. Obstet Gynecol. 1974;44:398–492
  15. Chang CHJ, Sibala JL, Lin F, et al. Computed tomographic evaluation of the breast. AJR Am J Roentgenol. 1978;131:459–464
  16. Heywang SH, Hahn D, Schmidt H, et al. MR imaging of the breast using Gadolinium-DTPA. J Comput Assist Tomogr. 1986;10:199–204
  17. Haase A, Frahm J, Matthaei D, et al. FLASH-Imaging: rapid NMR imaging using low flip angle pulses. J Magn Res. 1986;67:258–268
  18. Kaiser WA, Oppelt A. KST der Mamma mit Schnellbildverfahren. MR’87, 2. Internationales Kernspintomographie Symposium, 29.1.-1.2.87, Garmisch-Partenkirchen, Referateband. In: Konstanz: Schnetztor-Verlag; 1987;p. 303–310
  19. Kaiser WA, E. Zeitler E. MR-imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology. 1989;170:681–686
  20. Heywang SH, Wolf A, Pruss E, et al. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology. 1989;171:95–103
  21. Kaiser WA, Kess H. Prototyp-Doppelspule für die Mamma-MR-Messung. Fortschr Röntgenstr. 1989;151:103–105
  22. Kaiser WA. Dynamic MR-breast imaging using a double breast coil: a step towards routine MR examination of the breast. Eur Frontiers Radiol. 1990;7:39–68
  23. Ercolani P, Giovagnoni A, Giuseppetti G. Imaging dinamico con rosonanza magnetica nella senologia diagnostica. Radiol Med Torino. 1991;82:422–426
  24. Hachiya J, Seki T, Okada M. MR imaging of the breast with Gd-DTPA enhancement: Comparison with mammography and ultrasonography. Radiat Med. 1991;9:232–240
  25. Hess T, Knopp MV, Brix G. Pharmakokinetische Analyse der Kontrastmittelanreicherung in der MRT beim Mammakarzinom. Zentralbl Radiol. 1993;147:969
  26. Stack JP, Redmond OM, Codd MB. Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology. 1990;174:491–494
  27. Boetes C, Strijk SP, Holland R, et al. False-negative MR imaging of malignant breast tumours. Eur Radiol. 1997;7:1231–1234
  28. Bone B, Aspelin P, Bronge L, et al. Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts. Acta Radiol. 1996;37(2):208–213
  29. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumour angiogenesis. Radiology. 1996;200:639–649
  30. Daldrup HE, Roberts TP, Muhler A, et al. Macromolecular contrast media for MR mammography (A new approach to characterizing breast tumours). Radiologe. 1997;37(9):733–740
  31. DeAngelis GA, de Lange EE, Miller LR, et al. MR imaging of breast implants. Radiographics. 1994;14:783–794
  32. el Kwae EA, Fishman JE, Bianchi MJ, et al. Detection of suspected malignant patterns in three-dimensional magnetic resonance breast images. J Digit Imaging. 1998;11(2):83–93
  33. Farria DM, Gorczyca DP, Barsky SH, et al. Benign phyllodes tumour of the breast: MR imaging features. AJR Am J Roentgenol. 1996;167(1):187–189
  34. Fischer U, von-Heyden D, Vosshenrich R, et al. Signal characteristics of malignant and benign lesions in dynamic 2D-MRT of the breast. Rofo. 1993;158(4):287–292
  35. Fobben ES, Rubin CZ, Kalisher L, et al. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation. Radiology. 1995;196(1):143–152
  36. Frankel SD, Sickles EA. Morphologic criteria for interpreting abnormalities seen at breast MR imaging. Radiology. 1997;202(3):633–634
  37. Gilles R, Guinebretiere JM, Lucidarme O, et al. Nonpalpable breast tumours: diagnosis with contrast-enhanced subtraction dynamic MR imaging. [published erratum appears in Radiology 1994;193(1):285] Radiology. 1994;191:625–631
  38. Gilles R, Guinebretiere JM, Shapeero LG, et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. Radiology. 1993;188:473–478
  39. Gilles R, Zafrani B, Guinebretiere JM, et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology. 1995;196:415–419
  40. Gorczyca DP, DeBruhl ND, Ahn CY, et al. Silicone breast implant ruptures in an animal model: comparison of mammography (MR imaging, US, and CT). Radiology. 1994;190(1):227–232
  41. Gorczyca DP. Bilateral surface coils in MR breast imaging: potential hazards. Radiology. 1993;186(3):906–907
  42. Graham RA, Homer MJ, Sigler CJ, et al. The efficacy of specimen radiography in evaluating the surgical margins of impalpable breast carcinoma. [see comments] AJR Am J Roentgenol. 1994;162:33–36
  43. Gribbestad IS, Nilsen G, Fjosne HE, et al. Comparative signal intensity measurements in dynamic gadolonium-enhanced MR mammography. J Magn Reson Imaging. 1994;4(3):477–480
  44. Harms SE, Flamig DP. Staging of breast cancer with MR imaging. Magn Reson Imaging Clin N Am. 1994;2(4):573–584
  45. Hochman MG, Orel SG, Powell CM, et al. Fibroadenomas: MR imaging appearances with radiologic-histopathologic correlation. Radiology. 1997;204:123–129
  46. Hoffmann U, Brix G, Knopp MV, et al. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med. 1995;33(4):506–514
  47. Hylton NM, Frankel SD. Imaging techniques for breast MR imaging. Magn Reson Imaging Clin N Am. 1994;2(4):511–525
  48. Knopp MV, Brix G, Junkermann HJ, et al. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin N Am. 1994;2(4):633–658
  49. Kuhl CK, Kreft BP, Hauswirth A, et al. MR mammography at 0.5 and 1.5 T (I. Comparison of image quality and sensitivity of MR mammography at 0.5 and 1.5 T). Rofo. 1995;162(5):381–389
  50. Kuhl CK, Seibert C, Sommer T, et al. Focal and diffuse lesions in dynamic MR-mammography of healthy probands. Rofo. 1995;163(3):219–224
  51. Kuwabara M. MRI of breast tumours with emphasis on histopathologic correlation. Nippon Igaku Hoshasen Gakkai Zasshi. 1991;51(11):1366–1374
  52. Morris EA, Schwartz LH, Dershaw DD, et al. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology. 1997;205(2):437–440
  53. Muller RD, Barkhausen J, Sauerwein W, et al. Assessment of local recurrence after breast-conserving therapy with MRI. J Comput Assist Tomogr. 1998;22(3):408–412
  54. Muller-Schimpfle M, Ohmenhauser K, Stoll P, et al. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology. 1997;203(1):145–149
  55. Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol. 1997;169:417–424
  56. Nunes LW, Schnall MD, Siegelman ES, et al. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. AJR Am J Roentgenol. 1997;169:409–415
  57. Orel SG, Hochman MG, Schnall MD, et al. High-resolution MR imaging of the breast: clinical context. Radiographics. 1996;16:1385–1401
  58. Orel SG. High resolution MR imaging of the breast. Semin Ultrasound CT MR. 1996;17(5):476–493
  59. Pedevilla M. Enhancement velocity not necessarily reflective of contrast material uptake in breast MR imaging. Radiology. 1997;205(2):580–581
  60. Peller M, Stehling MK, Sittek H, et al. Effects of partial volume and phase shift between fat and water in gradient-echo magnetic resonance mammography. MAGMA. 1996;4(2):105–113
  61. Piccoli CW. The specificity of contrast-enhanced breast MR imaging. Magn Reson Imaging Clin N Am. 1994;2(4):557–571
  62. Pierce WB, Harms SE, Flamig DP, et al. Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast (Work in progress). Radiology. 1991;181(3):757–763
  63. Rieber A, Zeitler H, Rosenthal H, et al. MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol. 1997;70(833):452–458
  64. Rodenko GN, Harms SE, Pruneda JM, et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. AJR Am J Roentgenol. 1996;167:1415–1419
  65. Seki T, Hachiya J, Nitatori T, et al. MR imaging for breast cancer. Nippon Geka Gakkai Zasshi. 1996;97(5):347–356
  66. Soderstrom CE, Harms SE, Copit DS, et al. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology. 1996;201(2):427–432
  67. Soo MS, Kornguth PJ, Walsh R, et al. Intracapsular implant rupture MR findings of incomplete shell collapse. J Magn Reson Imaging. 1997;7:724–730
  68. Stelling CB. MR imaging of the breast for cancer evaluation (Current status and future directions). Radiol Clin North Am. 1995;33(6):1187–1204
  69. Van Goethem M, Van Breusegem L, Ceulemans R, et al. Infraclinical breast carcinoma. J Belge Radiol. 1995;78(1):6–10
  70. Weinreb JC, Newstead G. Controversies in breast MRI. Magn Reson Q. 1994;10(2):67–83
  71. Weinreb JC, Newstead G. MR imaging of the breast. Radiology. 1995;196(3):593–610
  72. Kaiser WA. Gegenwärtiger Stand der MR-Mammographie. Fortschr Röntgenstr 165. 1996;5:425–427Editorial
  73. Hussman K, Renslo R, Phillips JJ, et al. MR mammographic localization (Work in progress). Radiology. 1993;189:915–917
  74. Kuhl CK, Elevelt A, Leutner CC, et al. Interventional breast MR imaging: clinical use of a stereotactic localization and biopsy device. Radiology. 1997;204:667–675
  75. Thiele J, Schneider JP, Franke P, et al. New method of MR-guided mammary biopsy. Fortschr Röntgenstr. 1998;168:374–379
  76. Doler W, Fischer U, Metzger I, et al. Stereotaxic add-on device for MR-guided biopsy of breast lesions. Radiology. 1996;200:863–864
  77. Mahfouz AE, Rahmouni A, Zylbersztejn C, et al. MR-guided biopsy using ultrafast T1- and T2-weighted reordered turbo fast low-angle shot sequences: feasibility and preliminary clinical applications. AJR Am J Roentgenol. 1996;167:167–169
  78. Wurdinger S, Noras H, Straube K, et al. New MRI-breast-coil for imaging and doublesided intervention: preliminary results. 1997;ECR‘97, European Congress of Radiology, 2.-7. March, European Radiology 7. S243, 1997
  79. de Souza NN, Kormos DW, Krausz T, et al. MR-guided biopsy of the breast after lumpectomy and radiation therapy using two methods of immobilization in the lateral decubitus position. J Magn Reson Imaging. 1995;5:525–528
  80. Silverman SG, Collick BD, Figueira MR, et al. Interactive MR-guided biopsy in an open-configuration MR imaging system. Radiology. 1995;197:175–182
  81. Pfleiderer SO, Reichenbach JR, Azhari T, et al. Dedicated double breast coil for magnetic resonance mammography imaging, biopsy, and preoperative localization. Invest Radiol. 2003;38(1):1–8
  82. Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumours. J Magn Reson Imaging. 1999;10(3):260–266
  83. Brix G, Schreiber W, Hoffmann U, et al. Methodological approaches to quantitative evaluation of microcirculation in tissues with dynamic magnetic resonance tomography. Radiologe. 1997;37(6):470–480
  84. Buckley DL, Drew PJ, Mussurakis S, et al. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging. 1997;7(3):461–464
  85. Algire GH. Visualizing cellular behavior in vivo. J Int Chir. 1953;13(4):381–384includes translations
  86. Gimbrone MA, Leapman SB, Cotran RS, et al. Tumour dormancy in vivo by prevention of neovascularization. J Exp Med. 1972;136(2):261–276
  87. Folkmann J, Long DM, Becker FF. Growth and metastasis of tumour in organ culture. Cancer Apr;. 1963;16:453–467
  88. Ottinetti A, Sapino A. Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions. Breast Cancer Res Treat. 1988;11(3):241–248
  89. Samejima N, Yamazaki KA. Study on the vascular proliferation in tissues around the tumour in breast cancer. Jpn J Surg. 1988;18(3):235–242
  90. Folkman J. Tumour angiogenesis. Adv Cancer Res. 1985;43:175–203
  91. Weidner N, Semple JP, Welch WR, et al. Tumour angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med. 1991;324(1):1–8
  92. Jensen HM, Chen I, DeVault MR, et al. Angiogenesis induced by “normal” human breast tissue: a probable marker for precancer. Science. 1982;218(4569):293–295
  93. Port RE, Knopp MV, Brix G. Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumours. Magn Reson Med. 2001;45(6):1030–1038
  94. Lucht RE, Knopp MV, Brix G. Classification of signal-time curves from dynamic MR mammography by neural networks. Magn Reson Imaging. 2001;19(1):51–57
  95. Knopp MV, Himmelhan N, Radeleff J, et al. Comparison of methods for quantifying contrast enhancement exemplified by dynamic MRI mammography. Radiologe. 2002;42(4):280–290
  96. Buckley DL, Drew PJ, Mussurakis S, et al. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging. 1997;7(3):461–464
  97. Kaiser WA. Magnetic-Resonance-Mammography (MRM). Heidelberg, Germany: Springer-Verlag; 1993;ISBN 3-540-55083-6.
  98. Kaiser WA. False positive results in dynamic MR-mammography (MRM)—frequency, causes and methods to avoid it. In:  Davis PL editors. Magnetic Resonance Imaging, MRI—Clinics of North America. vol 2.4:Philadelphia, PA: Saunders; 1994;p. 539–555
  99. Neubauer H, Li M, Kuehne-Heid R, et al. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol. 2003;76(901):3–12
  100. Fischer DR, Baltzer P, Malich A, et al. Is the “blooming sign” a promising additional tool to determine malignancy in MR mammography?. Eur Radiol. 2003;14(3):394–401Epub 2003 Sep 27
  101. Liberman L. Sensitivity and specificity of mammography, MRI, and ultrasonography for detecting tumors in high-risk women. New Engl J Med. 2004;351(5):497–500
  102. Kaiser WA. Breast, Unit 21. In:  Haake EM,  Lin W,  Cheng NYC editor. Current Protocols in Magnetic Resonance Imaging. New York, NY: Wiley; 2004;
  103. Pfleiderer SO, Sachse S, Sauner D, et al. Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res. 2004;6(3):R232–R238Epub 2004 Mar 16
  104. Woodhams R, Hata H, Iwabuchi K, et al. Is diffusion-weighted imaging helpful for differentiating benign from malignant lesions?. Eur Radiol Suppl. 2006;16(suppl 5):E98–E99
  105. Mountford C, Stanwell P, Doran S, et al. DCIS can be diagnosed by magnetic resonance spectroscopy. Eur Radiol Suppl. 2006;16(suppl 5):E65–E67
  106. Kaiser WA, Selig M, Jung R, et al: Patentanmeldung: Manipulator für einen geschlossenen Magnetresonanztomographen (MRT). Patent Application Nr. 19941019.4; 28.08.1999, German Patent Office
  107. Pfleiderer SO, Reichenbach JR, Azhari T, et al. A manipulator system for 14-gauge large core breast biopsies inside a high-field whole-body MR scanner. J Magn Reson Imaging. 2003;17(4):493–498
  108. Pfleiderer SO, Freesmeyer MG, Marx C, et al. Cryotherapy of breast cancer under ultrasound guidance: initial results and limitations. Eur Radiol. 2002;12(12):3009–3014Epub 2002 Jun 21
  109. Jeffrey SS, Birdwell RL, Ikeda DM, et al. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg. 1999;134(10):1064–1068
  110. Hilger I, Leistner Y, Berndt A, et al. Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells. Eur Radiol. 2004;14(6):1124–1129Epub 2004 Apr 30

PII: S0037-198X(07)00043-0

doi: 10.1053/j.ro.2007.07.003

Seminars in Roentgenology
Volume 42, Issue 4 , Pages 228-235 , October 2007

Article Tools

* Image Usage & Resolution